![Jean Fan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Jean Fan currently works at TransThera Sciences (Nanjing), Inc., as Chief Medical Officer from 2022 and NeoImmuneTech, Inc., as Chief Clinical Officer from 2021.
Dr. Fan also formerly worked at Blueprint Medicines Corp., as Vice President-Clinical Development.
Jean Fan active positions
| Companies | Position | Start |
|---|---|---|
| NEOIMMUNETECH, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
| TRANSTHERA SCIENCES (NANJING), INC. | Chief Tech/Sci/R&D Officer | 2022-10-31 |
Former positions of Jean Fan
| Companies | Position | End |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
34
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
NeoImmuneTech, Inc.
 NeoImmuneTech, Inc. BiotechnologyHealth Technology Develops novel immuno-therapeutics | Health Technology |
TransThera Sciences (Nanjing), Inc.
 TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focusing on discovering and developing small molecule therapies | Health Technology |
- Stock Market
- Insiders
- Jean Fan
